ID   TR-iBRB2
AC   CVCL_J379
DR   Wikidata; Q54972890
RX   Patent=US20020045254;
RX   PubMed=11161732;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-6507.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [Note=tsA58].
CC   Derived from site: In situ; Eye, retina, capillary; UBERON=UBERON_0003501.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5U66 ! TR-iBRB4
OI   CVCL_5U67 ! TR-iBRB6
OI   CVCL_5U68 ! TR-iBRB8
OI   CVCL_5U69 ! TR-iBRB9
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 10
//
RX   Patent=US20020045254;
RA   Hosoya K.-i., Terasaki T., Ueda M., Obinata M.;
RT   "Established cells.";
RL   Patent number US20020045254, 18-Apr-2002.
//
RX   PubMed=11161732; DOI=10.1006/exer.2000.0941;
RA   Hosoya K.-i., Tomi M., Ohtsuki S., Takanaga H., Ueda M., Yanai N.,
RA   Obinata M., Terasaki T.;
RT   "Conditionally immortalized retinal capillary endothelial cell lines
RT   (TR-iBRB) expressing differentiated endothelial cell functions derived
RT   from a transgenic rat.";
RL   Exp. Eye Res. 72:163-172(2001).
//
RX   PubMed=11520047; DOI=10.1006/bbrc.2001.5247;
RA   Obinata M.;
RT   "Possible applications of conditionally immortalized tissue cell lines
RT   with differentiation functions.";
RL   Biochem. Biophys. Res. Commun. 286:667-672(2001).
//
RX   PubMed=17233813; DOI=10.1111/j.1349-7006.2007.00399.x;
RA   Obinata M.;
RT   "The immortalized cell lines with differentiation potentials: their
RT   establishment and possible application.";
RL   Cancer Sci. 98:275-283(2007).
//